Autopsy report · NCT02375048

Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: WBI Versus APBI

“number of enrollments not reached in the estimated time”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years before it stopped.
• 179 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Istituto Clinico Humanitas

Sponsor type

University, hospital or other

Conditions

Cancer of Breast

Interventions

Hypofractionated WBI; Accelerated Partial Breast Irradiation

Participants

179

Sites

1

Countries

Italy

Trials that died the same way

• A Post Market Study on DRG Stimulation in FBSS (SYMPATHY)
  “Lack of enrollments” (72% match in meaning)
• Family Nurture Intervention in the CHoNJ NICU
  “insufficient enrollment numbers” (72% match in meaning)
• 30 Day Rehospitalization Risk in Hemodialysis Patients
  “Lack of enrollment as expected” (72% match in meaning)
• Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma
  “Insufficient enrollment rate” (71% match in meaning)
• A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
  “Lack of enrollment” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.